Pneumatic Vitreolysis With Intravitreal Air for Focal Vitreomacular Traction.

Autor: Seamone ME; Department of Ophthalmology & Visual Sciences, University of Alberta, Edmonton, Alberta, Canada., Rubin U; Department of Ophthalmology & Visual Sciences, University of Alberta, Edmonton, Alberta, Canada., Grewal PS; Department of Ophthalmology & Visual Sciences, University of Alberta, Edmonton, Alberta, Canada., Greve M; Department of Ophthalmology & Visual Sciences, University of Alberta, Edmonton, Alberta, Canada.
Jazyk: angličtina
Zdroj: Journal of vitreoretinal diseases [J Vitreoretin Dis] 2020 Nov 06; Vol. 5 (4), pp. 348-353. Date of Electronic Publication: 2020 Nov 06 (Print Publication: 2021).
DOI: 10.1177/2474126420962649
Abstrakt: Purpose: To determine whether pneumatic vitreolysis with intravitreal air is effective for focal vitreomacular traction (VMT).
Methods: We conducted a retrospective consecutive case series of 20 eyes from 19 individuals with focal VMT who underwent pneumatic vitreolysis with intravitreal air (January 2017 to November 2018). We analyzed patients via spectral-domain optical coherence tomography before intravitreal air injection and at 1 month. The primary outcome measure was release of VMT.
Results: We observed release of VMT in 55% of individuals. An analysis limited to phakic eyes demonstrated release of VMT in 69%, and 65% developed improved best-corrected visual acuity. Individuals with persistent VMT and visual improvement had a significant reduction in angle of vitreoretinal insertion ( P < .01), area under VMT ( P < .05), and subfoveal cyst area ( P < .05).
Conclusions: Intravitreal air is an effective treatment for focal VMT. In individuals with persistent VMT, visual-acuity improvement was associated with a reduction in overall VMT.
Competing Interests: The author(s) declare no conflict of interest with respect to the research, authorship, and/or publication of this article.
(© The Author(s) 2020.)
Databáze: MEDLINE